Rare insights from industry experts on successful strategies for developing the next generation of blockbuster antiviral drugs
Contributed by industry experts with a background in discovering new drugs and therapies, Trends in Antiviral Drug Development describes successful development efforts for antiviral compounds and therapies that have entered the market or are currently in clinical trials. Viruses are arranged by their target tissue, consistent with contemporary drug development focusing on tissue-targeted therapies. Other key trends in antiviral therapy, such as efforts to develop long-acting drugs, are described for each virus type, enabling readers to follow the current and future status in this key area of ​​contemporary drug development.
Trends in Antiviral Drug Development Trends in Antiviral Drug Development include discussions of:
New drugs against herpes viruses as well as advanced drugs that have cured HCV
siRNA therapies, a novel antiviral approach, and drug candidates that are progressing toward a cure for HBV
Drugs that target viral entry, such as HIV entry through binding, co-receptor binding, and integration
New therapies against tropical diseases such as dengue fever and monkeypox
Trends in Antiviral Drug Development is an essential read for medicinal chemists, pharmaceutical chemists, virologists, and all professionals seeking to understand new ideas and approaches to combat the growing world of viral infections.
